I
IDXX
IDEXX Laboratories
635.66
4.93+0.78%After Hours: 636.27 +0.61 +0.10%16:54 02/20 EST
OPEN/PREV CLOSE626.75/630.73
TODAY RANGE625.22-638.14
VOL301.70K
MARKET CAP50.76B
52 WEEK RANGE356.14-769.98
AVG VOL (3M)519.35K
% TURNOVER0.38%
TURNOVER--
P/E (TTM)48.61
% RANGE2.05%
EPS(TTM)13.08
P/E(FORWARD)43.63
P/B31.62
BVPS20.10
DIVIDEND--
P/S11.79
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP50.41B
SHARES OUTSTANDING79.85M
NEXT EARNINGS04/29-05/04
FREE FLOAT79.30M
LOT SIZE1
EX-DATE06/16/2015
News
Press Releases
Financial Reports
Profile
MarketWatch·1d ago
Henry Schein Inc. stock outperforms competitors on strong trading day
TipRanks·2d ago
Top Idexx Leaders Quietly Cash In On Major Stock Sale
Reuters·2d ago
IDEXX EVP Michael G. Erickson Disposes of Common Shares
Seeking Alpha·2d ago
Baron Asset Fund adds Axon in Q4, sells Trade Desk
Simply Wall St·2d ago
Assessing IDEXX Laboratories (IDXX) Valuation After Q4 Beat And Cautious 2026 Outlook
Seeking Alpha·5d ago
Baron Partners Fund Q4 2025 Contributors And Detractors
TipRanks·02/13 22:31
Idexx Laboratories Announces Director Retirement and Board Changes
Simply Wall St·02/13 12:29
Should Strong 2025 Results and 2026 Outlook for CAG Diagnostics Recurring Revenue Require Action From IDEXX Laboratories (IDXX) Investors?
Reuters·02/12 21:15
IDEXX Laboratories Executives to Present at Major Investor Conferences
Reuters·02/12 16:10
UPDATE 1-Zoetis forecasts upbeat 2026; pet‑care market pressure drags shares
Reuters·02/12 13:30
Zoetis forecasts strong 2026 profit, revenue on steady pet‑medicine demand
Same Industry
Name/Symbol
Change%
Price